{"meta":{"query_hash":"fb63722942bf","filters":{"venue":"Kidney Cancer Journal"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/fb63722942bf","api":"https://metacan.xera.ac/api/v1/cohort?venue=Kidney+Cancer+Journal"},"results":[{"id":"W3207058551","doi":"10.52733/kcj19n3-a1","title":"Tissue based biomarkers in non-clear cell RCC: Correlative analysis from the ASPEN clinical trial","year":2021,"lang":"en","type":"article","venue":"Kidney Cancer Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Duke Clinical Research Institute; National Cancer Institute; Cancer Research UK; National Institutes of Health; Pfizer","keywords":"Chromophobe cell; Sunitinib; Everolimus; Medicine; Renal cell carcinoma; Clinical endpoint; Biomarker; Clear cell; Oncology; Internal medicine; Clear cell renal cell carcinoma; Response Evaluation Criteria in Solid Tumors; Clinical trial; Pathology; Phases of clinical research; Biology","score_opus":0.05026666963239548,"score_gpt":0.36535789552615133,"score_spread":0.3150912258937558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207058551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838373,0.0070404634,0.00078181096,0.00047911803,0.00010266832,0.0012897231,0.0041458555,0.000024547677,0.0022985714],"genre_scores_gemma":[0.9844795,0.0016553182,0.0014866646,0.00067865936,0.000167055,0.0015318531,0.009352981,0.000012732547,0.00063522795],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99435174,0.0037023278,0.0005083053,0.0005192163,0.00066659093,0.00025175803],"domain_scores_gemma":[0.99090487,0.0034240424,0.003149871,0.001012381,0.0008290617,0.00067966484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01126593,0.00065944367,0.0019466145,0.00039180752,0.00041739296,0.0015690902,0.0006104192,0.0009949034,0.0018865606],"category_scores_gemma":[0.010209488,0.00027200623,0.0012287801,0.0009912467,0.00064485223,0.0013356018,0.0007940877,0.001179811,0.0003396238],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62162685,0.0065539232,0.2617629,0.002757191,0.0085462555,0.00051193906,0.00035957596,0.0038957507,0.0053480156,0.00089383515,0.005795232,0.08194865],"study_design_scores_gemma":[0.14036138,0.1516081,0.6489829,0.00056936214,0.0104593625,0.0015250064,0.0004163124,0.0065971627,0.0055659716,0.0029743274,0.030771703,0.00016843512],"about_ca_topic_score_codex":0.00037976506,"about_ca_topic_score_gemma":0.0011163162,"teacher_disagreement_score":0.01126593,"about_ca_system_score_codex":0.0005839126,"about_ca_system_score_gemma":0.001309312,"threshold_uncertainty_score":0.059580684},"labels":[],"label_agreement":null},{"id":"W4220965877","doi":"10.52733/kcj20n1-gu2","title":"ASCO GU22 – Kidney Cancer Highlights","year":2022,"lang":"en","type":"article","venue":"Kidney Cancer Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Kidney cancer; Cancer; Prostate cancer; Medicine; Genitourinary system; Renal cell carcinoma; Bladder cancer; Kidney; Oncology; Internal medicine; Gynecology","score_opus":0.02028934703914708,"score_gpt":0.3071120769885514,"score_spread":0.28682272994940433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220965877","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014469859,0.1271435,0.0007778801,0.18554167,0.45370775,0.00055409654,0.005510804,0.0005159177,0.22480138],"genre_scores_gemma":[0.010270084,0.10127437,0.00084540976,0.059001997,0.5522884,0.00040177742,0.009344042,0.0003891168,0.26618475],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99844235,0.00024720025,0.00011522001,0.00017032132,0.0007151135,0.00030983833],"domain_scores_gemma":[0.9952655,0.00038306197,0.00024235707,0.000097724725,0.0017679841,0.0022434168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002864676,0.0013131297,0.00087228697,0.0017151958,0.001257994,0.0044152685,0.001247905,0.0041446057,0.10596717],"category_scores_gemma":[0.0042646467,0.0004035185,0.0012511004,0.0011785323,0.00038311825,0.0015604813,0.001853405,0.0041231615,0.051261906],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004752567,0.000013731178,0.000058158246,0.00022778953,0.0000061864716,0.000077013436,0.000004868174,0.000019091764,0.00009152918,0.00027577416,0.9779278,0.021250525],"study_design_scores_gemma":[0.00002570292,0.000034843408,0.00061807554,0.00027193106,0.0000093181825,0.00018624267,0.000012868673,0.000020172876,0.00007462858,0.000211302,0.99852955,0.0000054775533],"about_ca_topic_score_codex":0.0024219723,"about_ca_topic_score_gemma":0.0055086655,"teacher_disagreement_score":0.10596717,"about_ca_system_score_codex":0.0026559175,"about_ca_system_score_gemma":0.003884567,"threshold_uncertainty_score":0.35449547},"labels":[],"label_agreement":null},{"id":"W4407003207","doi":"10.52733/kcj22n4-r1","title":"piRNAs and PIWI-Like Proteins in Renal Cell Carcinoma: A Systematic Review of Emerging Biomarkers and Potential Therapeutic Targets","year":2024,"lang":"en","type":"review","venue":"Kidney Cancer Journal","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Piwi-interacting RNA; Renal cell carcinoma; Biology; Cancer research; Medicine; Computational biology; Bioinformatics; Internal medicine; RNA; Genetics; RNA interference","score_opus":0.01711396828479383,"score_gpt":0.30631317145413695,"score_spread":0.2891992031693431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407003207","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005766281,0.99869823,0.000082622384,0.00017331836,0.00004760831,0.000052962103,0.0002600311,0.0000033304857,0.00010520354],"genre_scores_gemma":[0.009092747,0.9896381,0.0004125816,0.00032318186,0.00006363518,0.00017436697,0.0002442703,0.0000025713969,0.000048625792],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99626285,0.0010137351,0.001625788,0.00037937687,0.000596288,0.00012200623],"domain_scores_gemma":[0.981934,0.013468373,0.0028923946,0.00023535878,0.0013001162,0.00016971456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054310914,0.001106927,0.0058101323,0.008076224,0.00039875324,0.0014809283,0.0012681609,0.0012662213,0.002695597],"category_scores_gemma":[0.020200776,0.00054851087,0.005527606,0.008672464,0.0005805654,0.0014968736,0.00091766316,0.0007882152,0.00020582679],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023979803,0.000014474669,0.0015561128,0.9283871,0.0082149245,0.00009064364,0.00010920528,0.00012412957,0.00026064235,0.00026043216,0.0016980042,0.059044532],"study_design_scores_gemma":[0.00030867115,0.00034861086,0.012052272,0.82908475,0.11335089,0.0007154811,0.0002903404,0.00022133542,0.0004156206,0.0006420949,0.04250568,0.000064352476],"about_ca_topic_score_codex":0.004286032,"about_ca_topic_score_gemma":0.010330082,"teacher_disagreement_score":0.008076224,"about_ca_system_score_codex":0.0017069645,"about_ca_system_score_gemma":0.0073556383,"threshold_uncertainty_score":0.028722644},"labels":[],"label_agreement":null}]}